CCA
CDNA icon

Catalyst Capital Advisors’s CareDx CDNA Stock Holding History

Catalyst Capital Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,000
Closed -$35K – 500
2014
Q3 		$35K Buy
+5,000
New +$48.1K ﹤0.01% 323

Other funds holding CDNA

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Catalyst Capital Advisors's CDNA Position: Q4 2014 in Review

Catalyst Capital Advisors sold out of CareDx (CDNA) in Q4 2014, closing a stake of 5,000 shares — an estimated $35K sold.

Catalyst Capital Advisors first reported a position in CDNA in Q3 2014 and held it in 1 quarter. The position peaked at $35K in Q3 2014. 19 funds tracked by Wall St. Rank hold CDNA as of Q4 2014.

  • Catalyst Capital Advisors reported no remaining CareDx position as of Q4 2014 after selling out during the quarter.
  • Catalyst Capital Advisors sold 5,000 CareDx shares in Q4 2014, an estimated $35K.
  • Catalyst Capital Advisors first reported a position in CareDx in Q3 2014 and held it in 1 quarter.
  • Catalyst Capital Advisors's CareDx position peaked at $35K in Q3 2014.
  • 19 funds tracked by Wall St. Rank held CareDx as of Q4 2014.

Based on Catalyst Capital Advisors's 13F filing for Q4 2014, filed 10 Feb 2015.